Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications.

Nat Commun · 2022 · PMC8854716 · PMID 35177642

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

approached significancep = 0.061so close (0.05 < p ≤ 0.1)

The median and interquartile range (IQR) for blood collection from severe (5 [IQR 4–7] days) versus mild-moderate groups (4 [IQR 2–6] days) approached significance ( t -test p = 0.061).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.